Deno Medical is a professional innovative life science and technology industry investment, incubation and operation enterprise, headquartered in Hangzhou, with overseas R&D centers in China, the United States and Israel (4 in the United States and 0 in Israel 1).
With the goal of filling the domestic gap and introducing world-leading technology, Deno Medical has discovered, invested and integrated medical projects with subversive innovative technologies in the world, and is committed to seeking effective treatment schemes for major diseases that seriously threaten human health but lack effective means at present.
Deno Medical has a strong team of international medical consultants (composed of famous clinicians and industry experts at home and abroad). With rich industry experience, the localization and industrialization of global innovative medical technology in China are realized by adopting the dual-track mode of independent innovation and introduction, digestion, absorption and re-innovation.
Deno Medical has a professional venture capital fund, which uses capital, resources and industry experience to incubate early domestic innovative life science and technology projects and accelerate their growth and industrialization. At the same time, joint venture funds introduce top foreign medical science and technology projects, and realize technology localization through digestion, absorption and innovation. At this stage, we focus on innovative diagnosis and treatment technologies, including cardiovascular diseases, tumors and diabetes.
Deno Medical adopts corporate management and operation mode, and all projects are settled in the form of project companies. In addition to providing GMP-compliant factory buildings, facilities and property services, Deno Medical also provides a series of specialized value-added services for the project company, including: technical consultation, legal consultation, market information service, patent service, animal experiment platform, clinical trial, medical device product registration, industrialization platform and market promotion.
By building a life science and technology industry innovation incubator with shared resources and services, Deno Medical has formed an open, integrated and sustainable life science and technology industry innovation ecosystem, created a number of industrial highlands and academic highlands in the domestic life science and technology field, promoted the coordinated development of industries, improved the academic status and international influence of domestic medical research institutions in related fields, and made contributions to the development of life science and technology industry in China.
Deno Medical has been built into an innovative platform with the latest international medical technology projects. At present, it has many projects such as lung cancer early diagnosis and treatment equipment (Broncus), peripheral vascular interventional equipment (Weiqiang Medical), structural heart disease interventional equipment (Nuomao Medical) and heart valve repair equipment (Dejin Medical).
Deno Medical Hangzhou Incubator has an incubation base of over10.2 million square meters in Binjiang District of Hangzhou, which is used for the production and operation of incubation projects. There are nearly 1000 employees including various incubation projects, including overseas employees 15%.